Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.67
Delayed Data
As of Jul 06
 +0.51 / +6.25%
Today’s Change
5.60
Today|||52-Week Range
12.46
+36.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.8M1.1M2.2M22.9M
 
 
 
 
 
Depreciation And Amortization4.9M4.2M2.9M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income-3.0M------
 
 
General Expenses103.5M95.4M103.9M101.2M
 
 
 
 
 
Research And Development91.8M78.4M89.7M84.4M
 
 
 
 
 
Total Operating Expenses108.4M99.6M106.8M103.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-106.5M-98.5M-104.6M-80.2M
 
 
 
 
 
Extraordinary Credit0.000.002.2M--
 
 
Extraordinary Charge-7.6M-9.9M0.00-20.1M
 
 
 
 
Interest Expense On Debt2.5M2.1M2.0M2.3M
 
 
 
 
 
Other Expenses153.0K105.0K59.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-116.2M-110.2M-104.1M-100.4M
 
 
 
 
 
Income Taxes0.000.000.00-70.0K
 
 
Net Income-116.2M-110.2M-104.1M-100.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.7M70.0M73.3M76.3M
 
 
 
 
 
Shares To Calculate EPS Diluted48.7M70.0M73.3M76.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.38-$1.61-$1.40-$1.33
 
 
 
 
 
EPS Diluted-$2.38-$1.61-$1.40-$1.33
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account